Nobel Award Recognizes Groundbreaking Immune System Discoveries

The Nobel Prize in Physiology or Medicine has been awarded for revolutionary discoveries that illuminate how the body's defense network targets harmful pathogens while sparing the healthy tissues.

A trio of esteemed researchers—Japan's Prof. Sakaguchi and American experts Dr. Brunkow and Dr. Ramsdell—received this honor.

Their work uncovered unique "security guards" within the immune system that eliminate rogue defense cells that could attacking the body.

The discoveries are now paving the way for new treatments for autoimmune diseases and cancer.

The laureates will divide a prize fund valued at 11 million Swedish kronor.

Decisive Discoveries

"Their research has been decisive for understanding how the body's defenses functions and why we do not all develop serious self-attack conditions," commented the chair of the award panel.

The team's studies address a fundamental mystery: How does the immune system defend us from countless invaders while keeping our healthy cells unharmed?

The body's protection system employs white blood cells that scan for signs of disease, even viruses and bacteria it has never encountered.

Such cells employ detectors—known as recognition units—that are produced randomly in countless variations.

This gives the immune system the capacity to fight a broad range of invaders, but the randomness of the process inevitably produces immune cells that can attack the body.

Protectors of the Immune System

Researchers previously understood that a portion of these harmful white blood cells were destroyed in the thymus—where white blood cells develop.

This year's award recognizes the discovery of regulatory T-cells—described as the immune system's "peacekeepers"—which patrol the body to neutralize any immune cells that assault the healthy cells.

We know that this process malfunctions in self-attack conditions such as type-1 diabetes, MS, and RA.

A Nobel panel stated, "These discoveries have established a novel area of research and spurred the development of new therapies, for instance for cancer and immune disorders."

Regarding malignancies, T-regs prevent the body from attacking the growth, so research are aimed at reducing their quantity.

For self-attack disorders, experiments are exploring boosting regulatory T-cells so the organism is no longer being harmed. A similar approach could also be useful in minimizing the risks of organ transplant failure.

Innovative Experiments

Prof Shimon Sakaguchi, from Osaka University, performed experiments on rodents that had their thymus extracted, causing autoimmune disease.

He showed that injecting immune cells from other animals could prevent the disease—suggesting there was a mechanism for blocking immune cells from harming the host.

Dr. Brunkow, from the a research center in a US city, and Dr. Ramsdell, now at Sonoma Biotherapeutics in a California city, were investigating an genetic immune disorder in mice and people that led to the identification of a genetic factor critical for how T-regs function.

"Their pioneering work has revealed how the body's defenses is kept in check by T-reg cells, stopping it from accidentally targeting the body's own tissues," said a prominent physiology specialist.

"The research is a striking example of how basic physiological research can have broad consequences for human health."